| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M304654200 |
| P698 | PubMed publication ID | 12777391 |
| P50 | author | Michael J. Quon | Q42818051 |
| Fabiana Bar-Yoseph | Q125314218 | ||
| Eddy Karnieli | Q125314258 | ||
| P2093 | author name string | Hui Chen | |
| Chava Harel | |||
| Michal Armoni | |||
| Natalia Kritz | |||
| P2860 | cites work | Transfection of DNA into isolated rat adipose cells by electroporation: evaluation of promoter activity in transfected adipose cells which are highly responsive to insulin after one day in culture | Q43509513 |
| Chromosomal Localization and Partial Genomic Structure of the Human Peroxisome Proliferator Activated Receptor-Gamma (hPPARγ) Gene | Q57242021 | ||
| Peroxisome proliterator-activated receptors, orphans with ligands and functions | Q57244375 | ||
| Insulin stimulation of GLUT-4 translocation: a model for regulated recycling | Q58480883 | ||
| Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension | Q22011018 | ||
| The organization, promoter analysis, and expression of the human PPARgamma gene | Q28244071 | ||
| 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma | Q29615221 | ||
| An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) | Q29615693 | ||
| mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer | Q29617271 | ||
| A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation | Q29619212 | ||
| PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance | Q29622888 | ||
| Rosiglitazone | Q33684266 | ||
| Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. | Q33967999 | ||
| PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer | Q34106716 | ||
| Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). | Q34206633 | ||
| A possible mechanism of insulin resistance in the rat adipose cell in streptozotocin-induced diabetes mellitus. Depletion of intracellular glucose transport systems | Q37003611 | ||
| Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency | Q37175466 | ||
| Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. | Q38343197 | ||
| Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase | Q38346718 | ||
| PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro. | Q40692581 | ||
| Facilitative glucose transporters | Q40717146 | ||
| A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis | Q40899355 | ||
| Glucose transport and NIDDM | Q41115289 | ||
| Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma | Q41144553 | ||
| Regulation of GLUT4 gene expression by arachidonic acid. Evidence for multiple pathways, one of which requires oxidation to prostaglandin E2. | Q41239821 | ||
| Troglitazone | Q41521276 | ||
| Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more.... | Q41651418 | ||
| Reversal of insulin resistance in diabetic rat adipocytes by insulin therapy. Restoration of pool of glucose transporters and enhancement of glucose-transport activity | Q42516879 | ||
| Sex differences in insulin action on glucose transport and transporters in human omental adipocytes | Q42517461 | ||
| P433 | issue | 33 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adipocyte | Q357519 |
| (RS)-rosiglitazone | Q424771 | ||
| P304 | page(s) | 30614-30623 | |
| P577 | publication date | 2003-05-29 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect | |
| P478 | volume | 278 |
| Q27677636 | (+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice |
| Q28741502 | A potential role for glucose transporters in the evolution of human brain size |
| Q24305362 | Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor {gamma} |
| Q42469480 | An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes. |
| Q38338967 | Chicken ovalbumin upstream promoter-transcription factor II regulates nuclear receptor, myogenic, and metabolic gene expression in skeletal muscle cells. |
| Q34452611 | Class II histone deacetylases limit GLUT4 gene expression during adipocyte differentiation |
| Q46288858 | Contractile activity per se induces transcriptional activation of SLC2A4 gene in soleus muscle: involvement of MEF2D, HIF-1a, and TRalpha transcriptional factors |
| Q28508812 | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes |
| Q39209941 | Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity |
| Q40522050 | Cytosolic phospholipase A2 Group IValpha but not secreted phospholipase A2 Group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors gamma 1 and 2 in human lung cell |
| Q54318425 | Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity. |
| Q39077948 | Di(2-ethylhexyl)phthalate exposure impairs insulin receptor and glucose transporter 4 gene expression in L6 myotubes |
| Q34395184 | Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL. |
| Q47696836 | Electroacupuncture plus metformin lowers glucose levels and facilitates insulin sensitivity by activating MAPK in steroid-induced insulin-resistant rats. |
| Q90522413 | Ellagic Acid and Urolithins A and B Differentially Regulate Fat Accumulation and Inflammation in 3T3-L1 Adipocytes While Not Affecting Adipogenesis and Insulin Sensitivity |
| Q38726891 | Evidences for diabetes and insulin mimetic activity of medicinal plants: Present status and future prospects |
| Q47621226 | Exposure of Pregnant Mice to Triclosan Causes Insulin Resistance via Thyroxine Reduction |
| Q36164341 | FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance |
| Q37129794 | FOXO-binding partners: it takes two to tango |
| Q40237087 | Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. |
| Q38322283 | Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements |
| Q49911816 | GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr-/- mice. |
| Q35842591 | Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes |
| Q37030803 | Gender-specific differences in PPARγ regulation of follicular helper T cell responses with estrogen |
| Q41094311 | HDAC3 is a molecular brake of the metabolic switch supporting white adipose tissue browning |
| Q45205488 | Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects |
| Q36250154 | Influence of different CLA isomers on insulin resistance and adipocytokines in pre-diabetic, middle-aged men with PPARγ2 Pro12Ala polymorphism |
| Q93039454 | Insulin-independent stimulation of skeletal muscle glucose uptake by low-dose abscisic acid via AMPK activation |
| Q37368638 | Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over study |
| Q39059715 | Mechanisms regulating GLUT4 transcription in skeletal muscle cells are highly conserved across vertebrates |
| Q42109973 | PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1 |
| Q24642728 | PPARs and the cardiovascular system |
| Q42504144 | Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytes |
| Q38633502 | Peroxisome proliferator-activated receptors and hepatitis C virus |
| Q35039274 | Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors |
| Q38205765 | Phytotherapy in diabetes: Review on potential mechanistic perspectives |
| Q37377433 | Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator |
| Q38809165 | Potent PPARγ Ligands from Swietenia macrophylla Are Capable of Stimulating Glucose Uptake in Muscle Cells. |
| Q39062062 | Prevention of nutritionally induced diabetes by rosiglitazone in the gerbil Psammomys obesus |
| Q98952064 | Progesterone receptor membrane associated component 1 enhances obesity progression in mice by facilitating lipid accumulation in adipocytes |
| Q36093005 | Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes |
| Q34114146 | Rare mutations of peroxisome proliferator-activated receptor gamma: frequencies and relationship with insulin resistance and diabetes risk in the mixed ancestry population from South Africa. |
| Q37025897 | Rosiglitazone : a review of its use in type 2 diabetes mellitus. |
| Q38893734 | Signaling pathways involved in cardiac energy metabolism |
| Q42423820 | Somatic cell plasticity and Niemann-pick type C2 protein: adipocyte differentiation and function |
| Q57124524 | Study of the effect of the herbal composition SR2004 on hemoglobin A1c, fasting blood glucose, and lipids in patients with type 2 diabetes mellitus |
| Q34514818 | Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models |
| Q58798692 | The Effect of L. Fruit Juice on the Blood Sugar Level and Other Serum Parameters in Patients with Diabetes Type 2 |
| Q38727651 | The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development. |
| Q37168807 | Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology |
| Q33802801 | Uteroplacental insufficiency increases visceral adiposity and visceral adipose PPARgamma2 expression in male rat offspring prior to the onset of obesity |
| Q35172969 | Zinc finger protein 407 (ZFP407) regulates insulin-stimulated glucose uptake and glucose transporter 4 (Glut4) mRNA |
Search more.